Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialtypharmaceutical company announced today that management will host aconference call to discuss second quarter results and provide abusiness update on Thursday, August 3, 2006, at 10:00 A.M. EDT.Bentley will release its results for the three and six months endedJune 30, 2006, before the open of the market on that day.
To participate on the live call, please dial (888) 332-7254 fromthe U.S. and Canada or, for international callers, please dial (973)582-2856 (access code 7679196), approximately 10 minutes prior to thescheduled start time. A telephone replay will be available for 30 daysby dialing (877) 519-4471 from the U.S. and Canada or (973) 341-3080for international callers (please reference reservation number7679196). The conference call will also be broadcast live on theInternet and may be accessed via Bentley's web site,www.bentleypharm.com. Please go to the Company's web siteapproximately 10 minutes prior to the scheduled start time toregister. A replay of the conference will also be available onBentley's web site for 30 days.
Bentley Pharmaceuticals, Inc. is a specialty pharmaceuticalcompany focused on advanced drug delivery technologies andpharmaceutical products. Bentley's proprietary drug technologiesenhance or facilitate the absorption of pharmaceutical compoundsacross various membranes. Bentley also manufactures a growingportfolio of generic and branded pharmaceuticals in Europe for thetreatment of cardiovascular, gastrointestinal, infectious andneurological diseases through its subsidiary, Laboratorios Belmac, andmarkets these pharmaceutical products through its subsidiaries,Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar andBentley Pharmaceuticals Ireland; and manufactures and markets activepharmaceutical ingredients through its subsidiary, Bentley API.
Additional information regarding Bentley Pharmaceuticals isavailable on Bentley's web site at www.bentleypharm.com.
